Note 1 - Overview and Basis of Presentation - Schedule of Unobservable Input Reconciliation (Details) - Fair Value of Contingent Consideration [Member] - USD ($) $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
|
| Balance | $ 4,150 | $ 6,450 | $ 535 | $ 535 |
| Purchases / Initial recognition | (2,300) | |||
| Included in earnings | (4) | |||
| Payments | (401) | |||
| Balance | $ 3,745 | $ 4,150 | $ 535 | $ 535 |
| X | ||||||||||
- Definition Amount of purchases net of adjustments of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|